Abstracts tagged "inflammation and magnetic resonance imaging (MRI)"

Abstract Number: 1802 • 2013 ACR/ARHP Annual Meeting
A Major Clinical Response To Anti-Tumor Necrosis Factor Agents Is Associated With a Reduced Development Of Fatty Changes In The Spine Of Patients With Ankylosing Spondylitis
Xenofon Baraliakos¹, Frank Heldmann², Joachim Listing³, Johanna Callhoff³ and Jürgen Braun², ¹Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³German Rheumatism Research Center, Berlin, Germany
Background/Purpose: Fatty changes (FC) on T1-weighted magnetic resonance images (MRI) have been described in the spine of patients with ankylosing spondylitis (AS). Such lesions were…
Abstract Number: 1119 • 2013 ACR/ARHP Annual Meeting
Quantification Of Inflammatory Disease Of Spine In Ankylosing Spondylitis Using Volumetric Magnetic Resonance Imaging Analysis
Ejaz Pathan¹, Adrian Lim², Andy Graham³, Keshthra Satchithananda², Dobrina Hull⁴, Sonya Abraham⁵, Anshul Rastogi⁶, Andrew Keat⁷, Mark Hinton⁸, Olga Kubassova⁹, Peter C. Taylor¹⁰ and J.V. Hajnal¹¹, ¹Clinical Trials Unit, Kennedy Institute of Rheumatology, London W6 8RF, United Kingdom, ²Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom, ³QABC Minster House, Image Analysis, London, United Kingdom, ⁴Clinical Trials Unit, The Kennedy Institute of Rheumatology, London, United Kingdom, ⁵Rheumatology, Charing Cross Hospital, Imperial college NHS trust London UK, London W6 8RF, United Kingdom, ⁶Radiology, Barts and the London NHS Trust, London, United Kingdom, ⁷Rheumatology, Northwick Park Hospital, Harrow, United Kingdom, ⁸Image Analysis Ltd, London, United Kingdom, ⁹Image Analysis Ltd., Leeds, United Kingdom, ¹⁰NDORMS, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, ¹¹Division of Imaging Sciences, King's College London, London, United Kingdom
Background/Purpose: To develop methodology for quantification of spinal inflammation in AS using a volumetric MRI-based technique and to explore relationships between these findings and clinical measures…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].